Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
Clinical trial NCT02611817 · COMPLETED
Trial details
- NCT number
- NCT02611817
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-04
- Primary completion
- 2019-05-06
- Enrollment
- 644
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.